首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >Optimal conditions of immune complex transfer enzyme immunoassays for antibody IgGs to HIV‐1 using recombinant p17 p24 and reverse transcriptase as antigens
【2h】

Optimal conditions of immune complex transfer enzyme immunoassays for antibody IgGs to HIV‐1 using recombinant p17 p24 and reverse transcriptase as antigens

机译:以重组p17p24和逆转录酶为抗原的HIV-1抗体IgG免疫复合物转移酶免疫测定的最佳条件

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The immune complex transfer enzyme immunoassays for antibody IgGs to p17, p24, and reverse transcriptase (RT) of HIV‐1 were tested under various conditions. Antibody IgGs to HIV‐1 were reacted for up to 20 hr with 2,4‐dinitrophenyl‐bovine serum albumin‐recombinant HIV‐1 protein conjugates and recombinant HIV‐1 protein‐β‐D‐galactosidase conjugates, and the immune complexes formed, comprising the three components, were trapped onto polystyrene beads coated with (anti‐2,4‐dinitrophenyl group) IgG by incubation at 4–30°C for up to 2 hr with shaking and were transferred onto polystyrene beads coated with (antihuman IgG γ‐chain) IgG in the presence of excess of ‐2,4‐dinitrophenyl‐L‐lysine by incubation at 4–30°C for up to 2 hr with shaking. When serum randomly collected from an HIV‐1 seropositive subject and serum included in an Western blot kit were tested, the formation of the immune complex was almost completed within 1 hr for antibody IgG to 17, within 1–2 hr for antibody IgG to p24 and within 4 hr for antibody IgG to RT. Even for antibody IgG to p17, however, the immune complex continued to be formed for at least 2 hr, when serum samples at early stages of HIV‐1 infection were tested. Trapping and transferring of the immune complexes were faster at higher temperatures and were almost completed within 0.5–1.5 hr, although the amount of the immune complexes trapped and transferred at 25 and/or 30°C increased for 0.5–1 hr, but subsequently tended to decline. When the formation, trapping, and transferring of the immune complexes were performed for 0.5, 1, and 1 hr, respectively, with shaking followed by 1 hr assay of bound β‐D‐galactosidase activity, the sensitivities for antibody IgGs to p17, p24, and RT using 10 μl of serum samples were similar to or significantly higher than those of the corresponding previous immune complex transfer enzyme immunoassays using 10 μl of serum samples, in which the formation, trapping, and transferring of the immune complexes were performed for 3, 16, and 3 hr, respectively, without shaking, followed by 2.5 hr assay of bound β‐D‐galactosidase activity, and the sensitivities for antibody IgGs to p17, p24, and RT using 100 μl of serum samples were 21–22‐fold, 5.5–6.3‐fold, and 5.3–6.0‐fold, respectively, higher. When each period of time for the formation, trapping, and transferring of the immune complexes was prolonged to up to 4 hr, the sensitivities for antibody IgGs to p17, p24, and RT using 100 μl of serum samples were improved 88–93‐fold, 15–17‐fold and 20–24‐fold, respectively, as compared with those of the previous ones. J. Clin. Lab. Anal. 12:98–107, 1998. © 1998 Wiley‐Liss, Inc.
机译:在各种条件下测试了针对HIV-1的p17,p24和逆转录酶(RT)的抗体IgG的免疫复合物转移酶免疫测定。 HIV-1抗体IgG与2,4-二硝基苯基-牛血清白蛋白重组HIV-1蛋白结合物和重组HIV-1蛋白-β-D-半乳糖苷酶结合物反应长达20小时,形成了免疫复合物,包含这三种成分的三聚体通过在4–30°C摇动孵育2小时而被捕获在涂有(抗2,4,4-二硝基苯基)IgG的聚苯乙烯珠上,然后转移到涂有(抗人IgGγ的聚苯乙烯珠上(链)IgG,在过量的2,4,2-二硝基苯基-L-赖氨酸存在下,通过在4–30°C下振荡孵育最多2小时。当对从HIV-1血清反应阳性的受试者中随机采集的血清和Western blot试剂盒中的血清进行测试时,对于抗体IgG至17,免疫复合物的形成几乎在1小时内完成;对于抗体p24,IgG在1-2小时内几乎完成了免疫复合物的形成。并在4小时内获得抗IgG的RT抗体。但是,即使是针对p17的IgG抗体,在检测HIV-1感染初期的血清样本时,免疫复合物仍会至少形成2小时。免疫复合物的诱捕和转移在较高的温度下更快,并且几乎在0.5-1.5小时内完成,尽管在25和/或30°C下捕获和转移的免疫复合物的量增加了0.5-1小时,但随后趋于稳定下降。分别进行0.5、1和1小时的免疫复合物的形成,诱捕和转移,然后摇动,然后1小时测定结合的β-D-半乳糖苷酶活性,这就是抗体IgG对p17,p24的敏感性和使用10μl血清样品的RT与使用10μl血清样品的相应先前免疫复合物转移酶免疫测定的相似或显着更高,其中免疫复合物的形成,捕获和转移进行了3次。分别摇晃16个小时,3个小时和3个小时,然后进行2.5个小时的结合β-D-半乳糖苷酶活性测定,使用100μl血清样品对IgG抗体对p17,p24和RT的敏感性为21-22-分别高出5.5倍,6.3-6.3倍和5.3-6.0倍。当免疫复合物的形成,捕获和转移的每个时间延长至4小时时,使用100μl血清样品对IgG抗体对p17,p24和RT的敏感性提高了88–93倍分别是以前的15到17倍和20到24倍。 J.临床实验室肛门1998年12:98-107。©1998 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号